Tenoxicam

Tenoxicam
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	M01AC02 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); UK: POM (Prescription only);
Pharmacokinetic data
Protein binding	High
Elimination half-life	30–140 hours
Identifiers
	IUPAC name (3E)-3-[hydroxy(pyridin-2-ylamino)methylene] -2-methyl-2,3-dihydro-4H-thieno[2,3-e] [1,2]thiazin-4-one 1,1-dioxide;
CAS Number	59804-37-4 ;
PubChem CID	5282194;
ChemSpider	4471584 ;
UNII	Z1R9N0A399;
KEGG	D01767 ;
ChEBI	CHEBI:32192 ;
CompTox Dashboard (EPA)	DTXSID8045486 ;
ECHA InfoCard	100.149.365
Chemical and physical data
Formula	C13H11N3O4S2
Molar mass	337.37 g·mol−1
Melting point	209 to 213 °C (408 to 415 °F) (dec.)
	(what is this?) (verify)

Tenoxicam, sold under the brand name Mobiflex among others, is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis (a type of arthritis involving the spine), tendinitis (inflammation of a tendon), bursitis (inflammation of a bursa, a fluid-filled sac located around joints and near the bones), and periarthritis of the shoulders or hips (inflammation of tissues surrounding these joints).

Tenoxicam belongs to the class of NSAIDs known as oxicams.

It was patented in 1974 by Roche and approved for medical use in 1987. It is available as a prescription-only drug in the United Kingdom and other countries, but not in the US. Outside the United Kingdom, tenoxicam is also marketed under brand names including Tilatil, Tilcitin, and Alganex.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.